During tumor progression, often accompanied by CC, this balance is disrupted [12], driven by the secretion of various pro-inflammatory catabolic factors by immune and cancer cells, such as tumor necrosis factor-α (TNFα) [13]. The gene discussed is TNF; the disease is neoplasm.